Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
about
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceCancer immunopreventionImmunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcomaThe role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.Lymphocytes in cancer development: polarization towards pro-tumor immunityCytokines and cancer immunotherapy.The role of interleukin-12 and interferon-gamma in GVHD and GVL.New insights into IL-12-mediated tumor suppression.IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside.Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis.Effect of Acute Maximal Exercise on Circulating Levels of Interleukin-12 during Ramadan Fasting.Defects in the interferon-gamma and interleukin-12 pathways.Multifaceted tumor stromal fibroblastsDifferential tumor surveillance by natural killer (NK) and NKT cells.Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.NKG2D function protects the host from tumor initiation.The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12.Genetic susceptibility of cervical cancer.Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex.Tumor immunoediting and immunosculpting pathways to cancer progression.Twelve immunotherapy drugs that could cure cancers.Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor responseDonor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas.Interleukin-12: clinical usage and molecular markers of cancer susceptibility.Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma.Increased expression of nonmuscle myosin IIs is associated with 3MC-induced mouse tumor.IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.Cancer immunotherapy.Eradication of established tumors in mice by a combination antibody-based therapy.Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population.Comparison of serum and tissue levels of trace elements in different models of cervical cancer.IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population.Cancer-preventing attributes of probiotics: an update.NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism.Effect of oral administration of Butyrivibrio fibrisolvens MDT-1, a gastrointestinal bacterium, on 3-methylcholanthrene-induced tumor in mice.A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.CD4 and CD8 T lymphocyte interplay in controlling tumor growth.
P2860
Q24670549-0DF8E028-E09A-4FB2-9716-51DA9A75E47CQ28303393-5DD95E56-5C48-40B4-BA81-E5B6195A8B92Q28389377-C9499C36-3BF9-4343-885B-B949D6FFEE84Q33643965-6175F350-4B40-4C57-9F19-03E8117BDDADQ33712435-E6DE414C-4AF2-4F78-96DC-585A64F7D9B0Q33943142-8188E6DF-7095-4413-AF39-BF179FB3E195Q34025160-BD32591A-74FC-4A91-A763-8790CC12FD56Q34436897-C66DBE56-1C28-4EBC-A958-215DE0D6D693Q34701390-3CF27B08-E6D5-435B-A308-CD295175D55DQ35234774-AE5664A2-6451-4018-BE6E-F7422D2175CBQ35786644-F5C86F96-77F4-4F42-8554-C4C036FC6565Q36015012-31FA858B-9482-4BA1-9278-18F2143D7097Q36284975-8054C68B-D4D5-4482-8E8D-0DF84507CF2BQ36375962-3A4572E8-A3D0-4ACA-9A96-F2A977D2A26EQ36401520-0536BBA6-777D-4C08-B33B-AF9C10DB3ADAQ36402828-648B5C4E-EA32-4E1B-9916-586B80E40661Q36430077-2D55C5A9-5041-4505-B63A-B5E5FF02E7ADQ36683202-CDEA75A7-90CD-4C36-A95B-E6D3A6FB6537Q36758009-F385F710-91DA-46D1-85E7-897536B6B066Q36896195-75934B30-A202-41A7-9ECF-E82E3C07CC86Q37118201-8C21BE82-23E7-4811-AD9F-99447B0D837BQ37350345-6681AE43-EF6B-4F87-8B75-8209437ABEE3Q37388260-AF1857D9-3F35-4096-884C-EB3400784B8CQ37565031-3915C1C8-B92A-41D5-BA27-BDFB4A8EE648Q38003641-F43B417C-9607-4BAC-ABD7-59A7010BF0E2Q38073753-4FCEE9BF-8AEE-4C3A-AC17-DCBAD1470EC9Q38915895-8544BAAE-4480-4090-9902-A02E611DA788Q39489140-B5AAEE99-36F8-4D4B-888B-C05F770D5811Q39645986-37CDF2F7-FB3B-49DF-8F58-A01CDAB7D462Q39958332-CC9715A8-BE9D-4CD4-B79F-73CF2E2EBB10Q40282761-F30BADB5-696F-4042-8F2F-7DC10416F0ACQ40885428-D5AF3CAD-6058-44E4-994B-BC70AB312AF8Q42222417-752AE159-A5D6-4947-8394-A20BCEE01FC3Q42997493-343BE35B-8C3D-4CD7-BCB7-4E809632D5F9Q43148199-44D2C761-3509-419A-9727-28FAD536C085Q43562662-06A4E115-6493-41F2-B371-62C73A0CB647Q43564045-DF027D51-9509-4027-BCB9-31E8F774AA22Q46957665-968258BB-C9C7-44EA-8F81-5197D312D012Q47195265-72BC7607-991F-4596-AB22-F7A492D98E92Q48185876-FB8F5F69-DE67-4C0B-B713-79E1B820AC15
P2860
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
@en
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.
@nl
type
label
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
@en
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.
@nl
prefLabel
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
@en
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.
@nl
P2093
P2860
P356
P1476
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
@en
P2093
P2860
P304
11798-11801
P356
10.1073/PNAS.93.21.11798
P407
P577
1996-10-01T00:00:00Z